Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 0 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 2 analysts offering 12 month price targets for Anika Therapeutics Inc have a median target of 26.50, with a high estimate of 28.00 and a low estimate of 25.00. The median estimate represents a 52.04% increase from the last price of 17.43.
High | 60.6% | 28.00 |
Med | 52.0% | 26.50 |
Low | 43.4% | 25.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 11, 2025.
Average growth rate | -5,216.50% |
Average growth rate | -452.94% |
More ▼
Revenue history & estimates in USD
Average growth rate | -1.54% |
Average growth rate | +9.88% |
More ▼